Hexavalent chromium detector
AssigneeYeda Research and Development Co. Ltd.
InventorsMilko E. Van Der Boom, Tarkeshwar Gupta, Graham De Ruiter
Life of this patent
Estimating the term…
Abstract
The present invention relates to a molecular-based system for the optical detection, quantification and detoxification of hexavalent chromium (Cr6+) by reversible metal-substrate electron transfer. More particularly, the invention provides a Cr6+ sensor device comprising a divalent osmium (Os2+)-, iron (Fe2+)- or ruthenium (R2+)-based pyridyl complex capable of changing its oxidation state in response to a reduction of Cr6+ at the presence of H+, thereby causing a reversible and optically readable change in optical properties of said complex. The Os2+-, Fe2+- or R2+-based pyridyl complex used according to the invention can be used for selective detection and quantification of Cr6+, as well as for catalytic detoxification of Cr6+.
Claims26
A method for selective detection and quantification of Cr6+ in a liquid sample, comprising:
- (i) exposing a divalent osmium (Os2+)-, iron (Fe2+)- or ruthenium (R2+)-based pyridyl complex capable of changing its oxidation state in response to a reduction of Cr6+ to said sample, for a sufficient time period at the presence of H+;
- (ii) recording absorption spectra of said pyridyl complex at the UV/visible spectral range, and
- (iii) monitoring the presence of Cr6+ in said sample and determining its concentration according to the change in the absorption spectra of (ii) compared to a predetermined absorption spectra of said pyridyl complex,
- wherein said pyridyl complex is a charged tris-bipyridyl Os2+, Fe2+ or R2+ complex of the general formula I:
- wherein M is Os, Fe or Ru;
- n is the formal oxidation state of the osmium, iron or ruthenium,
- wherein n is 2 or 3;
- m is the positive charge of the tris-bipyridyl ligand, wherein m is an integer from 0 to 24,
- X is a counter anion selected from Br−, Cl−, F−, I−, PF6−, BF4−, OH−, ClO4−, SO3− CF3COO−, CN−, alkylCOO−, arylCOO− or a combination thereof;
- R5 to R28 is each independently hydrogen, halogen, hydroxyl, azido, nitro, cyano, amino, substituted amino, thiol, C1-C10 alkyl, cycloalkyl, heterocycloalkyl, haloalkyl, aryl, heteroaryl, alkoxy, alkenyl, alkynyl, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, sulfonyl, substituted aryl, substituted cycloalkyl or substituted heterocycloalkyl,
- wherein at least one of said R5 to R28 is a group A or B:
- wherein group A is
- wherein
- group A is linked to the ring structure of the compound of general formula I via R4;
- R4 is cis/trans C═C, C≡C, N═N, C═N, N═C, C—N, N—C, alkylene, arylene or a combination thereof;
- R3 is C or N;
- R2 is absent or is hydrogen, alkyl, alkylene, aryl, arylene, OH, O-alkyl, O-alkylene or a combination thereof;
- R1 is absent or is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- group B is −O(CH2)p—R29 linked to the ring structure of the compound of general formula I via the oxygen, wherein p is an integer from 9 to 12;
- R29 is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- and
- any two vicinal R5-R28 substituents, together with the carbon atoms to which they are attached, may form a fused ring system selected from cycloalkyl, heterocycloalkyl, heteroaryl or aryl, wherein said fused system may be substituted by one or more groups selected from C1-C10 alkyl, aryl, azido, cycloalkyl, halogen, heterocycloalkyl, alkoxy, hydroxyl, haloalkyl, heteroaryl, alkenyl, alkynyl, nitro, cyano, amino, substituted amino, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, thiol, sulfonyl or substituted aryl;
- and said fused ring system may also contain at least one heteroatom selected from the group consisting of N, O and S.
A method for detoxification of Cr6+ in an aqueous or organic liquid media, comprising:
- (i) contacting said liquid media with a divalent osmium (Os2+)-, iron (Fe2+)- or ruthenium (Ru2+)-based pyridyl complex capable of changing its oxidation state to Os3+-, Fe3+- or Ru3+-based pyridyl complex, respectively, in response to a reduction of Cr6+, for a sufficient time period at the presence of H+, wherein said pyridyl complex is carried as a layered structure on a substrate;
- (ii) monitoring the presence of Cr6+ and determining its concentration in a sample taken from said liquid media;
- and
- when Cr6+ is detected in said sample, reducing said Os3+-, Fe3+- or Ru3+-based pyridyl complex and repeating steps (i) and (ii) wherein said pyridyl complex is a charged tris-bipyridyl Os2+, Fe2+ or Ru2+ complex of the general formula I:
- wherein M is Os, Fe or Ru;
- n is the formal oxidation state of the osmium, iron or ruthenium,
- wherein n is 2 or 3;
- m is the positive charge of the tris-bipyridyl ligand, wherein m is an integer from 0 to 24,
- X is a counter anion selected from Br−, Cl−, F−, I−, PF6−, BF4−, OH−, ClO4−, SO3−, CF3COO−, CN−, alkylCOO−, arylCOO− or a combination thereof;
- R5 to R28 is each independently hydrogen, halogen, hydroxyl, azido, nitro, cyano, amino, substituted amino, thiol, C1-C10 alkyl, cycloalkyl, heterocycloalkyl, haloalkyl, aryl, heteroaryl, alkoxy, alkenyl, alkenyl, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, sulfonyl, substituted aryl, substituted cycloalkyl or substituted heterocycloalkyl,
- wherein at least one of said R5 to R28 is a group A or B:
- wherein group A is
- wherein
- group A is linked to the ring structure of the compound of general formula I via R4;
- R4 is cis/trans C═C, C≡C, N═N, C═N, N═C, C—N, N—C, alkylene, arylene or a combination thereof;
- R3 is C or N;
- R2 is absent or is hydrogen, alkyl, alkylene, aryl, arylene, OH, O-alkyl, O-alkylene or a combination thereof;
- R1 is absent or is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- group B is —O(CH2)p—R29 linked to the ring structure of the compound of general formula I via the oxygen, wherein p is an integer from 9 to 12;
- R29 is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- and
- any two vicinal R5-R28 substituents, together with the carbon atoms to which they are attached, may form a fused ring system selected from cycloalkyl, heterocycloalkyl, heteroaryl or aryl, wherein said fused system may be substituted by one or more groups selected from C1-C10 alkyl, aryl, azido, cycloalkyl, halogen, heterocycloalkyl, alkoxy, hydroxyl, haloalkyl, heteroaryl, alkenyl, alkynyl, nitro, cyano, amino, substituted amino, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, thiol, sulfonyl or substituted aryl;
- and said fused ring system may also contain at least one heteroatom selected from the group consisting of N, O and S.
A method for detoxification of Cr6+ in an aqueous or organic liquid media, comprising contacting said liquid media with a divalent osmium (Os2+)-, iron (Fe2+)- or ruthenium (Ru2+)-based pyridyl complex capable of changing its oxidation state to Os3+-, Fe3+- or Ru3+-based pyridyl complex, respectively, in response to a reduction of Cr6+, for a sufficient time period at the presence of H+, wherein said pyridyl complex is carried as a layered structure on a substrate
- wherein said pyridyl complex is a charged tris-bipyridyl Os2+, Fe2+ or Ru2+ complex of the general formula I:
- wherein M is Os, Fe or Ru;
- n is the formal oxidation state of the osmium, iron or ruthenium,
- wherein n is 2 or 3;
- m is the positive charge of the tris-bipyridyl ligand, wherein m is an integer from 0 to 24,
- X is a counter anion selected from Br−, Cl−, F−, I−, PF6−, BF4−, OH−, OH4−, SO3−, CF3COO−, CN−, alkylCOO−, arylCOO− or a combination thereof;
- R5 to R28 is each independently hydrogen, halogen, hydroxyl, azido, nitro, cyano, amino, substituted amino, thiol, C1-C10 alkyl, cycloalkyl, heterocycloalkyl, haloalkyl, aryl, heteroaryl, alkoxy, alkenyl, alkynyl, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, sulfonyl, substituted aryl, substituted cycloalkyl or substituted heterocycloalkyl,
- wherein at least one of said R5 to R28 is a group A or B:
- wherein group A is
- wherein
- group A is linked to the ring structure of the compound of general formula I via R4;
- R4 is cis/trans C═C, C≡C, N═N, C═N, N═C, C—N, N—C, alkylene, arylene or a combination thereof;
- R3 is C or N;
- R2 is absent or is hydrogen, alkyl, alkylene, aryl, arylene, OH, O-alkyl, O-alkylene or a combination thereof;
- R1 is absent or is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- group B is —O(CH2)p—R29 linked to the ring structure of the compound of general formula I via the oxygen, wherein p is an integer from 9 to 12;
- R29 is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- and
- any two vicinal R5-R28 substituents, together with the carbon atoms to which they are attached, may form a fused ring system selected from cycloalkyl, heterocycloalkyl, heteroaryl or aryl, wherein said fused system may be substituted by one or more groups selected from C1-C10 alkyl, aryl, azido, cycloalkyl, halogen, heterocycloalkyl, alkoxy, hydroxyl, haloalkyl, heteroaryl, alkenyl, alkynyl, nitro, cyano, amino, substituted amino, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, thiol, sulfonyl or substituted aryl;
- and said fused ring system may also contain at least one heteroatom selected from the group consisting of N, O and S.
A catalytic process for reduction of Cr6+, comprising reducing said Cr6+ with a divalent osmium (Os2+)-based pyridyl complex of the general formula I:
- wherein M is Os;
- n is the formal oxidation state of the osmium, iron or ruthenium, wherein n is 2 or 3;
- m is the positive charge of the tris-bipyridyl ligand, wherein m is an integer from 0 to 24, X is a counter anion selected from Br−, Cl−, F−, I−, PF6−, BF4−, OH−, ClO4−, SO3−, CF3COO−, CN−, alkylCOO−, arylCOO− or a combination thereof;
- and R5 to R28 is each independently hydrogen, halogen, hydroxyl, azido, nitro, cyano, amino, substituted amino, thiol, C1-C10 alkyl, cycloalkyl, heterocycloalkyl, haloalkyl, aryl, heteroaryl, alkoxy, alkenyl, alkynyl, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, sulfonyl, substituted aryl, substituted cycloalkyl or substituted heterocycloalkyl, wherein at least one of said R5 to R28 is a group A or B:
- wherein group A is
- and wherein
- group A is linked to the ring structure of the compound of general formula I via R4;
- R4 is cis/trans C═C, C≡C, N═N, C═N, N═C, C—N, N—C, alkylene, arylene or a combination thereof;
- R3 is C or N;
- R2 is absent or is hydrogen, alkyl, alkylene, aryl, arylene, OH, O-alkyl, O-alkylene or a combination thereof;
- R1 is absent or is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- group B is —O(CH2)p—R29 linked to the ring structure of the compound of general formula I via the oxygen, wherein p is an integer from 9 to 12;
- R29 is hydrogen, trialkoxysilane, trihalidesilane, thiol, COOH, COO−, Si(OH)3 or phosphonate;
- any two vicinal R5-R28 substituents, together with the carbon atoms to which they are attached, may form a fused ring system selected from cycloalkyl, heterocycloalkyl, heteroaryl or aryl, wherein said fused system may be substituted by one or more groups selected from C1-C10 alkyl, aryl, azido, cycloalkyl, halogen, heterocycloalkyl, alkoxy, hydroxyl, haloalkyl, heteroaryl, alkenyl, alkynyl, nitro, cyano, amino, substituted amino, carboxamido, substituted carboxamido, carboxyl, protected carboxyl, protected amino, thiol, sulfonyl or substituted aryl;
- and said fused ring system may also contain at least one heteroatom selected from the group consisting of N, O and S,
- to thereby oxidize the Os2+ to Os3+, and exposing the oxidized Os3+ to water for a sufficient time period to thereby regenerate the Os3+ to Os2+.
Dependencies are inferred from the claim text.